DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Ubicación actual:
>
> This Story


Conexión o Registro to rate this News Story
Forward Printable StoryPrint Comment

 

 

Business Affairs Homepage

Brainlab to become distributor of Elekta's stereotactic neurosurgery products in US Already the supplier in select European markets

Q&A with David Pacitti, President of Siemens Medical Solutions USA, Inc. and Head of Siemens Healthineers North America Insights from the show floor at RSNA

3-D printed middle-ear to correct hearing loss shows promise at RSNA Further evidence of CT and 3-D printing synergy

Hitachi acquires Mitsubishi Electric’s particle therapy system business Will integrate with Hitachi's own particle therapy division to form one entity

Philips acquires VitalHealth for an undisclosed amount Adds to its population health management portfolio

Edwards acquires Harpoon Medical Company now owns the image-guiding HARPOON System

Dignity Health, Catholic Health Initiatives agree to merge into giant, new Catholic health system Will provide care in 28 states

Image Diagnostics monitor to be enhanced with new video management system Add-on to the first large field 4k mobile and multi-modality monitor

Top 10 trends and takeaways from RSNA 2017 Are radiologists going the way of the dodo bird? Of course not / Yes, yes they are

Frans van Houten, CEO of Philips, on the future of radiology Discussing the demands for relevant innovations and the arrival of 'clinical data scientists'

CVS takes Aetna in $69 billion deal

por Thomas Dworetzky , Contributing Reporter
“CVS Health, the largest pharmacy health care provider in the U.S., has agreed to acquire Aetna,” Aetna chairman and CEO Mark Bertolini announced in a statement Sunday.

He reassured members that the deal “will have no immediate effect on your benefits,” adding that, “we will use CVS Health’s footprint of more than 9,700 retail stores and 1,100 in-store clinics to establish entirely new community health hubs dedicated to improving consumer well-being and answering questions about health, prescription drugs and health care benefits.”

Story Continues Below Advertisement

Ask Any Woman. She Wants a Better Breast Imaging Experience.

SoftVue Can Bring It. In today's healthcare environment, a positive patient experience is central in providing excellent patient care. This is where SoftVue comes in - click to read more>>>



“We think of it as creating a new front door to health care in America,” said CVS Health’s chief executive, Larry J. Merlo, according to the The New York Times.

The deal will give Aetna shareholders $145.00 per share in cash and 0.8378 CVS Health shares for each Aetna share, which values Aetna at about $207 per share.

Aetna stated that the deal would fill “an unmet need" in the current health care system “increasing numbers of consumers are taking on more and more responsibility for paying for their health care as the burden of costs is being shifted to them,” according to the company.

The deal, if it passes regulatory hurdles, will offer consumers a more “integrated” experience, claims the company.

“We are obviously going to get some scrutiny,” said Bertolini according to Bloomberg News. “We are prepared to deal with whatever comes along to make this work.”

It could save the combined firms around $750 million.

It will also allow a vertical integration that some say is a response to fears surrounding Amazon's potential to disrupt the market.

Such deals have usually won approval in the past, but that may not be true going forward – as evidenced by the suit by the DOJ to block a similar vertical deal between AT&T and Time Warner.

“Most vertical deals don’t raise antitrust concerns, and the ones that do generally get approval to close with an agreement containing behavioral conditions,” according to Jennifer Rie, a Bloomberg Intelligence analyst. “But the Justice Department appears to be rejecting this kind of remedy, given its approach to the AT&T-Time Warner deal.”

Michael Newshel, an analyst at Evercore ISI, told Bloomberg that Aetna could be required to unload its Medicare-related drug business either in part or completely to seal the deal, advising that it “would definitely be scrutinized, but ultimately we still see a path for it to get through.”
  Pages: 1 - 2 >>

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente su conciencia de marca
Subastas + ventas Privadas
Consigue el mejor precio
Comprar Equipo/Piezas
Encuentra El Precio Más Bajo
Noticias diarias
Lee las últimas noticias
Directorio
Examina todos los usuarios DOTmed
Ética en DOTmed
Ver nuestro programa de ética
El oro parte programa del vendedor
Recibir las solicitudes de PH
Programa de distribuidor con servicio gold
Recibe solicitudes
Proveedores de atención de salud
Ver todos los HCP (abreviatura de asistencia médica) Herramientas
Trabajos/Entrenamiento
Encontrar/rellenar un trabajo
Parts Hunter +EasyPay
Obtener presupuestos para piezas
Certificado recientemente
Ver usuarios certificados recientemente
Recientemente clasificado
Ver usuarios certificados recientemente
Central de alquiler
Alquila equipos por menos
Vende equipos/piezas
Obtén más dinero
Mantenga el foro de los técnicos
Buscar ayuda y asesoramiento
Petición sencilla de propuestas
Obtén presupuestos para equipos
Feria comercial virtual
Encuentra servicio para el equipo
El acceso y el uso de este sitio está conforme a los términos y a las condiciones de nuestro AVISO LEGAL & AVISO DE LA AISLAMIENTO
Característica de y propietario DOTmeda .com, inc. Copyright ©2001-2017 DOTmed.com, Inc.
TODOS LOS DERECHOS RESERVADOS